Permanent Interstitial Brachytherapy for the Management of Carcinoma of the Prostate Gland
Authors:
- 1 May 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 169 (5) , 1643-1652
Abstract
We summarize the permanent prostate brachytherapy literature, including biochemical outcomes, quality of life parameters and areas of controversy. The permanent prostate brachytherapy literature was reviewed using MEDLINE searches to ensure completeness. Using various planning and intraoperative techniques the majority of the brachytherapy literature demonstrates durable biochemical outcomes for patients with low, intermediate and high risk features. For low risk patients there is no advantage to combining supplemental external beam radiation therapy with brachytherapy. In addition, supplemental external beam radiation therapy may not improve biochemical outcomes for patients at intermediate and high risk if the target volume consists of the prostate with a generous periprostatic margin. There is no defined role for adjuvant hormonal manipulation. Although a reliable set of pretreatment criteria to predict implant related morbidity is not available, severe urinary and rectal morbidity is rare. The incidence of brachytherapy induced erectile dysfunction is significantly greater than initially reported but the majority of patients respond favorably to sildenafil. Continued refinements in brachytherapy planning and implementation techniques, postimplantation evaluation and continued elucidation of the etiology of urinary, bowel and sexual dysfunction should result in further improvements in biochemical and quality of life outcomes.Keywords
This publication has 66 references indexed in Scilit:
- Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapyUrology, 2002
- Late urinary function after prostate brachytherapyBrachytherapy, 2002
- Five-year biochemical outcome after prostate brachytherapy for hormone-naive men ≤ 62 years of ageInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- Temporal resolution of urinary morbidity following prostate brachytherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- Prostate brachytherapy in patients with prostate volumes ≥ 50 cm3: dosimetic analysis of implant qualityInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- American brachytherapy society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
- Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable diseaseUrology, 1999
- IDENTIFICATION OF PATIENTS AT INCREASED RISK FOR PROLONGED URINARY RETENTION FOLLOWING RADIOACTIVE SEED IMPLANTATION OF THE PROSTATEJournal of Urology, 1998
- Age-Related Prostate Cancer MetastasesUrology, 1998
- Low risk of urinary incontinence following prostate brachytherapy in patients with a prior transurethral prostate resectionInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1997